Generics
24 April 2019 - - Israeli drugmaker Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) (TASE: TEVA) has provided an update that the company is discontinuing the clinical development program for use of f...
24 April 2019 - - Israeli drugmaker Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) (TASE: TEVA) has launched a generic version of VESIcare 1 (solifenacin succinate) Tablets, 5 mg and 10 mg...
24 April 2019 - Israel-based Teva Pharmaceutical Industries Ltd (NYSE and TASE: TEVA) has launched a generic version of VESIcare (solifenacin succinate) Tablets, 5mg and 10mg, in the United States, it...
23 April 2019 - Biopharmaceutical company Oakrum Pharma LLC revealed on Monday the launch of an agreement to develop and manufacture two prescription generic pharmaceutical products to be commercialis...
23 April 2019 - Teva Pharmaceutical Industries Ltd (Teva) (TASE:TEVA) (HYSE:TEVA) announced on Monday the launch of a generic version of VESIcare 1 (solifenacin succinate) tablets, 5 mg and 10 mg, in ...
23 April 2019 - Phyton Biotech, a German/North American Plant Cell Fermentation technology company, and AqVida, a German oncology Finished Dosage Formulation (FDF) manufacturer, have received European...